These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 23740960)
1. Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review. Smith SJ; Smith BD Br J Ophthalmol; 2013 Oct; 97(10):1231-6. PubMed ID: 23740960 [TBL] [Abstract][Full Text] [Related]
2. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Smith SJ; Smith BD; Mohney BG Br J Ophthalmol; 2014 Mar; 98(3):292-7. PubMed ID: 24187047 [TBL] [Abstract][Full Text] [Related]
3. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track. Munier FL; Soliman S; Moulin AP; Gaillard MC; Balmer A; Beck-Popovic M Br J Ophthalmol; 2012 Aug; 96(8):1084-7. PubMed ID: 22368262 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Munier FL; Gaillard MC; Balmer A; Soliman S; Podilsky G; Moulin AP; Beck-Popovic M Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968 [TBL] [Abstract][Full Text] [Related]
6. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds. Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261 [TBL] [Abstract][Full Text] [Related]
7. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds. Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530 [TBL] [Abstract][Full Text] [Related]
8. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture. Shields CL; Douglass AM; Beggache M; Say EA; Shields JA Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319 [TBL] [Abstract][Full Text] [Related]
9. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report. Chao A; Kao LY; Liu L; Wang NK BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871 [TBL] [Abstract][Full Text] [Related]
10. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537 [TBL] [Abstract][Full Text] [Related]
11. Assessment of retinoblastoma RNA reflux after intravitreal injection of melphalan. Winter U; Nicolas M; Sgroi M; Sampor C; Torbidoni A; Fandiño A; Chantada GL; Munier FL; Schaiquevich P Br J Ophthalmol; 2018 Mar; 102(3):415-418. PubMed ID: 29089355 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal injection of melphalan for intraocular retinoblastoma. Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017 [TBL] [Abstract][Full Text] [Related]
13. The role of intravitreal chemotherapy for retinoblastoma. Manjandavida FP; Shields CL Indian J Ophthalmol; 2015 Feb; 63(2):141-5. PubMed ID: 25827545 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma. Rao R; Honavar SG; Sharma V; Reddy VAP Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050 [TBL] [Abstract][Full Text] [Related]
15. Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy. Francis JH; Abramson DH; Ji X; Shields CL; Teixeira LF; Schefler AC; Cassoux N; Hadjistilianou D; Berry JL; Frenkel S; Munier FL JAMA Ophthalmol; 2017 Dec; 135(12):1426-1429. PubMed ID: 29098285 [TBL] [Abstract][Full Text] [Related]
16. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859 [TBL] [Abstract][Full Text] [Related]
17. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma. Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Ghassemi F; Shields CL Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma. Lawson BM; Saktanasate J; Say EA; Shields CL J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e92-4. PubMed ID: 25490242 [TBL] [Abstract][Full Text] [Related]